DelMar Pharmaceuticals News

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

03.04.24	Kintara Therapeutics To Merge Into TuHURA Biosciences (RTTNews)
07.12.23	Kintara Announces Review Of Strategic Alternatives To Maximize Stockholder Value (RTTNews)
31.10.23	Kintara Therapeutics Suspends Development Of VAL-083 In Glioblastoma; Stock Drops (RTTNews)
29.06.23	Pre-market Movers: SGTX, WAVE, BTAI, KTRA, CRMD… (RTTNews)
28.11.22	Kintara Therapeutics Rallies As Its REM-001 To Treat Breast Cancer Gets Fast Track Designation (RTTNews)
28.11.22	Kintara: FDA Grants Fast Track Designation To REM-001 Therapy - Quick Facts (RTTNews)
19.10.22	Kintara Decides To Pause REM-001 Program - Quick Facts (RTTNews)
15.06.22	Kintara Therapeutics Granted Fast Track Designation For VAL-083 (RTTNews)
12.04.22	Kintara Announces $8.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (PR Newswire)
11.04.22	Kintara Therapeutics Presents Data at the 2022 American Association for Cancer Research Annual Meeting (PR Newswire)
22.03.22	Kintara Therapeutics to Present at the Maxim Group 2022 Virtual Growth Conference (PR Newswire)
15.03.22	Kintara Therapeutics Announces Data Presentation at the 2022 American Association for Cancer Research Annual Meeting (PR Newswire)
25.01.22	Pre-market Movers: APM, BSFC, INPX, UPC, KAVL… (RTTNews)
21.01.22	Pre-market Movers: BSFC, APM, KTRA, RIOT, PIXY… (RTTNews)
13.10.21	Pre-market Movers: WTRH, NEW, RGLS, KOSS, PROC… (RTTNews)
22.09.21	Kintara: Topline Results From Adjuvant Arm Affirms Efficacy Of VAL-083 (RTTNews)
17.08.21	Kintara Therapeutics Provides Positive Site Activation Update on GCAR Phase 2/3 Clinical Trial for Glioblastoma (PR Newswire)
12.08.21	Kintara Therapeutics to Present at the Investor Summit Virtual Conference on August 17, 2021 (PR Newswire)
04.08.21	Kintara Therapeutics to Present at the BTIG Virtual Biotechnology Conference on August 9, 2021 (PR Newswire)
01.07.21	Kintara Reports Positive Phase 2 Trial On Recurrent Glioblastoma Multiforme; Stock Surges (RTTNews)
01.07.21	Kintara Reports Topline Results From Phase 2 Clinical Trial of VAL-083 for Recurrent GBM (PR Newswire)
06.01.21	Pre-market Movers In Healthcare Sector: ISR, GHSI, NMTR, CHEK, BBI… (RTTNews)
19.11.20	Pre-market Movers In Healthcare Sector: APVO, CORT, TTNP, BLU, MGTX... (RTTNews)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	49.91	0.87 %	K V
Geberit	529.60	0.84 %	K V
Part Grp Hldg	1’270.50	0.36 %	K V
CieFinRichemont	121.45	0.21 %	K V
UBS Group	28.13	0.18 %	K V
Givaudan	3’856.00	-0.31 %	K V
Zurich Insur Gr	554.20	-0.32 %	K V
Swisscom	508.00	-0.39 %	K V
Nestle	76.28	-0.47 %	K V
Swiss Life Hldg	712.80	-1.22 %	K V